U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that Charles Goodyear performed some of his experiments on rubber while in debtor's prison? He was there so often he referred to it as his "hotel". Chronically in debt because of poor business sense and ill health, Goodyear depended on the generosity of friends and family. Even after he unlocked the secret to vulcanizing rubber, he was unable to improve his financial situation. When he died, his estate was $200,000 in debt.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 556/1 - HEAVY METAL CONTAINING (e.g., Ga, In or T1, etc.)


Subclass of Class 556 - Organic compounds -- part of the class 532-570 series
Definition: Compounds under Class 532, ... , which contain a heavy
No. of applications: 67
Last issue date: 05/24/2012


1    
Application No.Application TitleIssue Date
20120128729Gallium Formulation For The Treatment And Prevention of Infectious Diseases
A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeru...
05/24/2012
20120128583DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME
The present invention relates to DTPA derivatives capable of forming complexes by combining with metals and the like, metal complexes formed by combining with the DTPA derivatives, MR and CT contrast agents including gold (Au) nano-particles of which surfaces are coated...
05/24/2012
20120009121PSMA-TARGETING COMPOUNDS AND USES THEREOF
Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described....
01/12/2012
20110247523ORGANIC-INORGANIC COMPOSITE PARTICLES, PARTICLE DISPERSION, PARTICLE-DISPERSED RESIN COMPOSITION, AND METHOD FOR PRODUCING ORGANIC-INORGANIC COMPOSITE PARTICLES
The organic-inorganic composite particles can be dispersed as primary particles in a solvent and/or a resin and have a plurality of mutually different organic groups on the surface of inorganic particles....
10/13/2011
20110165089Complex Compound and MRI Probe Made of Same
Novel gadolinium complex compounds responsive to ions and compounds other than zinc ion, as well as MRI probes made of the compounds are disclosed. Since the gadolinium complex compounds of the present invention such as that represented by the following structural formu...
07/07/2011
20110137061NANOINK FOR FORMING ABSORBER LAYER OF THIN FILM SOLAR CELL AND METHOD OF PRODUCING THE SAME
A nanoink composition for forming an absorber layer of a thin film solar cell comprises particles and a volatile chelating agent mixing with the particles. The particles contain one or more elements selected from group IB and/or IIIA and/or VIA. In the present invention...
06/09/2011
20110065944NEW REACTIONS OF FULLERENES
A process for producing a fullerene derivative. The process comprises reacting a fullerene compound with a primary amine in the presence of a peroxide....
03/17/2011
20110038809Growth control of oral and superficial microorganisms using gallium compounds
The present invention provides methods for treating or preventing diseases and disorders caused by iron-dependent pathogenic microorganisms, such as bacteria, fungi, and parasites, by applying a gallium compound to an affected area. In particular, the present invention ...
02/17/2011
20110034713Ortho-metalated, chelate-stabilized benzylamines of the rare-earth metals (RE) Ar3RE
The present invention describes homoleptic, ortho-metalated, chelate-stabilized benzylamine complexes of the rare-earth metals. The rare-earth metals are selected from Sc, Y, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu. In the complexes according to the p...
02/10/2011
20110033379RADIO-LABELED MATERIALS AND METHODS OF MAKING AND USING THE SAME
Radio-labeled materials, e.g., compounds and compositions, methods of making the radio-labeled materials, and applications of the same are disclosed. For example, novel solid-state methods are disclosed that produce radio-labeled compositions that include a reactive, bu...
02/10/2011
20110028748NOVEL HYBRID ORGANIC-INORGANIC MATERIAL IM-19 AND METHOD OF PREPARING SAME
The invention relates to a novel hybrid organic-inorganic material containing an inorganic network of metal centres based on the element gallium, connected to each other by organic bridges, to the preparation and to the use thereof. The invention also relates to an inte...
02/03/2011
20100324319Tame based chelators and uses thereof
New bifunctional chelation complexes are described. These are based on the structure of the so-called “TAME-HexA” molecule. The compounds are especially useful for forming chelation complexes with metal ions, including radioisotopes....
12/23/2010
20100301219Metal-Organic Scintillator Crystals for X-Ray, Gamma Ray, and Neutron Detection
New metal-organic materials are useful as scintillators and have the chemical formula LX3(CH3OH)4 where L is Y, Sc, or a lanthanide element, and X is a halogen element. An example of the scintillator materials is CeCl3(CH...
12/02/2010
20100292495METHOD FOR THE RECOMBINANT PRODUCTION OF MAGNETIC NANOPARTICLES
The present invention relates to methods and compositions for the size-adjusted recombinant production of magnetic nanoparticles. More particular, the invention relates to a method, comprising: providing one or more cells being capable of producing magnetic nanoparticle...
11/18/2010
20100284860MOLECULES SUITABLE FOR BINDING TO A METAL LAYER FOR COVALENTLY IMMOBILIZING BIOMOLECULES
An article is provided for immobilizing functional organic biomolecules (e.g. proteins, DNA, and the like) through a covalent bond to a thiolate or disulfide monolayer to a metal surface wherein an extra activation step of the surface layer or an activation step of the ...
11/11/2010
20100286263Gallium complexes with polyalcohols and methods of use
Provided are complexes of gallium and polyalcohols. Also provided are pharmaceutical compositions comprising such complexes and methods of their use. Methods of preparing the complexes are also provided....
11/11/2010
20100286022EDIBLE AND BIOCOMPATIBLE METAL-ORGANIC FRAMEWORKS
The disclosure relates generally to materials that comprise organic frameworks. The disclosure also relates to materials that are useful to store and separate biological agents that are environmentally friendly and biocompatible....
11/11/2010
20100267967MULTIFUNCTIONAL METAL-CHELATING LIGANDS
Disclosed herein are the compounds shown below and methods of their synthesis. The value m is a positive integer. R comprises an alkyl chain or an alkoxy chain. Each X comprises a metal binding group. Each E is a methoxy group or comprises a biomolecule reactive group o...
10/21/2010
20100256407Method of Synthesizing Phosphide Materials
The subject of the invention is a method of synthesizing a compound MxPy where M is an element belonging to one of columns II to XV of the Periodic Table of the Elements or to the family of lanthanides or to the family of actinides, characterized i...
10/07/2010
20100254912Gadolinium containing prussian blue nanoparticles as nontoxic MRI contrast agents having high relaxivity
Gadolinium+3 (Gd3+) containing (or incorporated) Prussian blue lattice contrast agents that can be used as an MRI contrast agent have unexpectedly improved r1 relaxivities of 1 or 2 magnitudes higher than the commercial Gd3+-c...
10/07/2010
20100221184Compositions for Delivery of Therapeutics and Other Materials
This disclosure relates to compositions for delivering agents to a subject, and in particular, to compositions for delivery of therapeutic agents or diagnostic agents in the presence or absence of targeting moieties. In part, this disclosure relates to compositions comp...
09/02/2010
20100178247CA-IX SPECIFIC RADIOPHARMACEUTICALS FOR THE TREATMENT AND IMAGING OF CANCER
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of ...
07/15/2010
20100098636Compositions for Delivery of Therapeutics and Other Materials
This disclosure relates to compositions for delivering agents to a subject, and in particular, to compositions for delivery of therapeutic agents or diagnostic agents in the presence or absence of targeting moieties. In part, this disclosure relates to compositions comp...
04/22/2010
20100092667ATOMIC LAYER DEPOSITION USING METAL AMIDINATES
Metal films are deposited with uniform thickness and excellent step coverage. Copper metal films were deposited on heated substrates by the reaction of alternating doses of copper(I) NN′-diispropylacetamidinate vapor and hydrogen gas. Cobalt metal films were deposited...
04/15/2010
20100041907HYDRAZINE-FREE SOLUTION DEPOSITION OF CHALCOGENIDE FILMS
A method of depositing a film of a metal chalcogenide including the steps of: contacting an isolated hydrazinium-based precursor of a metal chalcogenide and a solvent having therein a solubilizing additive to form a solution of a complex thereof; applying the solution o...
02/18/2010
20100013055METHOD FOR PRODUCING TRIALKYL GALLIUM
The present invention provides a method for producing a trialkyl gallium comprising the steps of reacting gallium, magnesium, and an alkyl halide in an ether, and diluting during the reaction the reaction system with an ether; a method for producing a trialkyl gallium c...
01/21/2010
20090264668METHOD FOR PRODUCTION OF FINEPARTICLE AND METHOD FOR PRODUCTION OF INDIUM ORGANOCARBOXYLATE
A method for producing fine particles having in their molecules at least one element “X” selected from P, As and Sb and at least one element “Y” selected from Ga, In, Zn, Cd, Si, Ge and Sn, the method comprising the steps of (a) mixing a raw material for said el...
10/22/2009
20090137773Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Forming Foams, and Foam Stabilizers
Compositions and methods for making compositions such as RF(Rτ)nQ are provided. The RF group can include at least two —CF3 groups, the Rτ group can be a group having at least two carbons, n can be at least 1, and the Q group can include one or more atoms of the peri...
05/28/2009
20090112012Synthesis of gallium and indium alkoxides
A method of synthesising gallium or indium alkoxide from the corresponding gallium or indium halide, the method comprising the step of reacting the gallium or indium metal halide with the alkoxide of an alkali earth metal, to produce the desired metal alkoxide essential...
04/30/2009
20090039771ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE
This invention provides an organic EL element, which can control luminescence wavelength, exhibits high luminescence efficiency, and has a prolonged emission life, and a lighting equipment and a display device. They can be realized by an organic electroluminescent eleme...
02/12/2009
20090036537AROMATIC TRIAMIDE-LANTHANIDE COMPLEXES
The present invention provides luminescent lanthanide metal chelates comprising a metal ion of the lanthanide series and a complexing agent comprising at least one phthalamidyl moiety. Also provided are probes incorporating the phthalamidyl ligands of the invention and ...
02/05/2009
20090030214Oxidation Process
Peroxo-carbonates derived from molten alkali and/or Group II metal salts, particularly carbonate salts are used as catalysts in oxidation and epoxidation reactions, transition metal compounds may be included to improve the selectivity of the reactions....
01/29/2009
20080296537Gas-phase functionalization of carbon nanotubes
In a method for functionalizing a carbon nanotube surface, the nanotube surface is exposed to at least one vapor including at least one functionalization species that non-covalently bonds to the nanotube surface, providing chemically functional groups at the nanotube su...
12/04/2008
20080297044Method for manufacturing metal sulfide nnocrystals using thiol compound as sulfur precursor
A metal sulfide nanocrystal manufactured by a method of reacting a metal precursor and an alkyl thiol in a solvent, wherein the alkyl thiol reacts with the metal precursor to form the metal sulfide nanocrystals, wherein the alkyl thiol is present on the surface of the m...
12/04/2008
20080271640Porogens, Porogenated Precursors and Methods for Using the Same to Provide Porous Organosilica Glass Films with Low Dielectric Constants
A porous organosilica glass (OSG) film consists of a single phase of a material represented by the formula SivOwCxHyFz, where v+w+x+y+z=100%, v is from 10 to 35 atomic %, w is from 10 to 65 atomic %, x is from 5 to ...
11/06/2008
20080233378TRANSPARENT, ELECTRICALLY CONDUCTIVE LAYER, A PROCESS FOR PRODUCING THE LAYER AND ITS USE
Transparent, electrically conductive layer, a process for producing the layer and its use, wherein the layer is based on at least one compound of the formula 1

wherein the substituents are as defined....

09/25/2008
20080226550SMALL TECHNETIUM-99M AND RHENIUM LABELED AGENTS AND METHODS FOR IMAGING TUMORS
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tumors, e.g., carcinomas, melanomas and other tumors. In another embodiment, the invention relates to methods of im...
09/18/2008
20080194679Compositions and methods for increasing metabolic activity in animal tissue
The present invention is directed to methods and compositions which include high nitrogen metal amino acid chelates that can increase the metabolic activity or metal concentration in animals. In one embodiment, an amino acid composition can comprise an amino acid chelat...
08/14/2008
20080166296Pharmaceutical Gallium Compositions and Methods
Novel pharmaceutical gallium compositions, including gallium complexes having increased oral bioavailablity relative to uncomplexed gallium salts are disclosed. Such compositions are useful in the treatment of conditions and diseases in which inhibition of abnormally in...
07/10/2008
20080111124Metallocenyl dendrimer, organic memory device using the same and fabrication method of the organic memory device
Disclosed are a metallocenyl dendrimer, an organic memory device using the metallocenyl dendrimer and a method for fabricating the organic memory device. The metallocenyl dendrimer may be composed of a dendrimer and metallocenes as redox species linked to the dendrimer....
05/15/2008
1    
 
Sign InRegister
Username  
Password   
forgot password?